Porocel acquires Medicine Hat catalyst processing facility from Criterion

Porocel International has acquired the Medicine Hat catalyst processing plant in Canada's Alberta province from Criterion Catalysts & Technologies, officials confirmed on Thursday.

The Medicine Hat facility will be Porocel’s fourth catalyst regeneration, rejuvenation and ex-situ presulfurization plant globally, adding to its sites in Lafayette, Louisiana), Luxembourg and Singapore. 

This acquisition strategically positions Porocel to service the growing Canadian catalyst market, according to company officials.

Porocel says it will achieve growth with a focused, continued emphasis on HSE, and will be introducing new and innovative technologies tied to catalyst regeneration, rejuvenation, ex-situ presulfurization and other related catalyst processing technologies.

Related News

From the Archive